Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
256.46
-3.75 (-1.44%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,729,804
Open
257.96
Bid (Size)
256.00 (100)
Ask (Size)
256.58 (500)
Prev. Close
260.21
Today's Range
255.58 - 258.91
52wk Range
190.75 - 267.47
Shares Outstanding
N/A
Dividend Yield
2.70%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King)
↗
Today 5:04 EDT
Owning these dividend stocks could be a simple way to make money over the long term.
Via
The Motley Fool
Topics
Intellectual Property
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 04, 2026
AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.
Via
The Motley Fool
Topics
Intellectual Property
Performance
YTD
+11.8%
+11.8%
1 Month
+4.2%
+4.2%
3 Month
+12.9%
+12.9%
6 Month
+11.5%
+11.5%
1 Year
+20.4%
+20.4%
More News
Read More
True Beauty Aesthetics Marks One-Year Milestone With Open House
September 02, 2026
Via
Press Advantage
AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 29, 2026
Via
The Motley Fool
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 29, 2026
Via
The Motley Fool
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
↗
August 26, 2026
Via
Benzinga
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy.
↗
August 26, 2026
Via
The Motley Fool
2 S&P 500 Stocks with Exciting Potential and 1 We Brush Off
August 25, 2026
Via
StockStory
Topics
Electric Vehicles
Stocks
World Trade
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
↗
August 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Dividend Stocks to Buy and Never Sell
↗
August 23, 2026
Via
The Motley Fool
Topics
Economy
The Dividend ETF That Generates Passive Income While You Sleep
↗
August 21, 2026
Via
The Motley Fool
Topics
ETFs
3 Unpopular Stocks That Deserve Some Love
August 21, 2026
Via
StockStory
Topics
Energy
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
↗
August 20, 2026
Via
The Motley Fool
Plastic Surgeon Dr. Young Cho Named to National MD Codes Faculty
August 19, 2026
Via
Press Advantage
Billionaire Ken Griffin Increased His Position in This Dividend King by 547%
↗
August 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026
From
Equity Insider
Via
GlobeNewswire
2 Dividend Stocks That Are No-Brainer Buys in August
↗
August 18, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year
↗
August 16, 2026
Via
The Motley Fool
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
↗
August 14, 2026
Via
The Motley Fool
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
From
USA News Group
Via
GlobeNewswire
2 Reasons to Like ABBV and 1 to Stay Skeptical
August 12, 2026
Via
StockStory
Topics
Stocks
Supply Chain
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 11, 2026
Via
The Motley Fool
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
↗
August 11, 2026
Via
The Motley Fool
Topics
Stocks
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?
↗
August 11, 2026
Via
The Motley Fool
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 256.46
When was AbbVie last traded?
The last trade of AbbVie was at 09/04/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.